by hendrixnuzzles | March 13, 2015 9:18 pm
Does anyone have opinion or insight into Cellectis and its potential ?
Have found very little opinion or analysis available on this company, apart from their website and a few terse press announcements (Pfizer and Servier agreements, gene splicing patents, decision to offer securities in the US) and dense technical explanations of their approach to CART therapy…allegedly unique in that it is allogenic, as opposed to autologous, meaning it can use 3rd party cultured cells instead of donor cells.
From what I understand this means they can potentially deliver an off-the-shelf product instead of a ”custom” one-patient-at-a-time process…
Based on the Pfizer and Servier investments I took a small position
and got lucky, the stock jumped on the announcement of a US offering. Would appreciate any insight anyone may have…
Source URL: https://www.stockgumshoe.com/2015/03/microblog-cellectis-romainville-biotech/
Copyright ©2024 Stock Gumshoe unless otherwise noted.
CMVLF- hendrixnuzzles, Cellectis has been and is discussed frequently on the biotechnology threads as well as the finest other equities in this sector. The knowledge, education and camaraderie here at stockgumshoe.com is second to none. Have an excellent weekend and beyond ALL!-Benjamin
Thanks. I saw your explanation of the technology on a thread, but you ventured no opinion on the stock. Their terse announcement of a US offering had no details of timing or number of shares, either.
hendrixnuzzles; I don’t think you are an ‘Irregular’ but for $49.00 you can get access to the Dr KSS Gumshoe biotechnology threads. Here is a sampling;
http://www.stockgumshoe.com/author/dr-kss-md-phd/
Thanks…I am a new subscriber and not completely familiar with how to follow all the threads…before posting I did see Sogiam’s detailed article about CART19 players, and looked at Dr KSS’ thread going back a few months where he explained a little about the technology at Cellectis. But he did not opine on the stock, and I have seen nothing in the threads since the company’s recent announcement of US offering and the recent spike to the $ 35-38 range.
Welcome Hendrixnuzzles. A thread that you may find useful is located here: http://www.stockgumshoe.com/2014/11/microblog-guidelines-for-new-members-posting-rules-and-etiquette/ The current bioerchnology thread is: http://www.stockgumshoe.com/2015/02/microblog-the-zed-files/ Best-Benjamin